Potential Risks and Considerations Even setting aside regulatory status, any consideration of growth hormone stimulating compounds requires awareness of potential risks that appear in the clinical and safety literature: Water retention and edema Joint pain (arthralgia), which is a known side effect of GH elevation Potential impact on insulin sensitivity GH affects glucose metabolism Theoretical concerns about stimulating GH in individuals with undiagnosed malignancies (GH is a growth factor) Unknown long-term effects from extended use in healthy adults Quality and purity concerns when obtained outside regulated pharmaceutical channels These considerations underscore why any decision regarding peptide therapy must involve a physician who can review individual medical history, contraindications, and current evidence not a wellness clinic, online pharmacy, or influencer recommendation
This includes both formulations plus administration fees
Steady state (Weeks 38): Continue the same daily dose
Cell Mol Life Sci 77:17451770 Lv S, Sylvestre M, Prossnitz AN, Yang LF, Pun SH (2021) Design of polymeric carriers for intracellular peptide delivery in oncology applications
p53 has a direct apoptogenic role at the mitochondria
doi: 10.1159/000339949 61 SigitovaE.FiarZ.HroudovJ.CiknkovT.RabochJ